Related Experiment Video

Updated: Jul 19, 2026

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

[Heart transplantation.]

G Sigfússon1

  • 1Childrens hospital, Landspitali University Hospital, Hringbraut, 101 Reykjavík, Iceland. gulli@landspitali.is.

Laeknabladid
|October 5, 2006
PubMed

Insights

Heart transplantation is a successful treatment for end-stage heart disease, offering good survival rates. Chronic rejection and immunosuppression complications remain key challenges for long-term patient success.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Context:

  • Heart transplantation is a recognized treatment for advanced heart failure in adults and children.
  • Current one-year survival rates are 85%, with five-year survival around 65%.

Purpose:

  • To review the current status of heart transplantation as a treatment for end-stage heart disease.
  • To identify the primary challenges and outcomes associated with heart transplantation.

Summary:

  • Heart transplantation offers significant survival benefits for patients with end-stage heart disease.
  • The main obstacle to long-term survival is chronic rejection, specifically post-transplant coronary artery disease.
  • While complications from immunosuppression therapy exist, patients generally report a good quality of life.

Impact:

  • Highlights the efficacy of heart transplantation while underscoring the need for improved strategies to combat chronic rejection.
  • Provides essential information for clinicians and researchers in the field of cardiac transplantation.
  • Emphasizes the importance of managing immunosuppression to optimize patient outcomes and quality of life post-transplant.

More Related Videos

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.